Pulpitis - IrreversibleNCT06811636
Lesion Sterilization Tissue Repair and Conventional Pulpectomy in Primary Molars
An observational study of Pulpitis - Irreversible and Pulp Necroses, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study was to compare the clinical and radiographic success of conventional root canal treatment and lesion sterilisation tissue repair methods in deciduous molars with necrotic or irreversible pulpitis. Read more about this study
- Who is it for?
- Ages 3 to 8 yearsHealthy volunteers can take part
- Conditions the study is for
- Pulpitis - Irreversible, Pulp Necroses, Root Canal Infection
- What is being tested?
- Lesion sterilization and tissue repair and Conventional pulpectomy
- Type of treatment
- Surgery or procedure
- How many people
- 59 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2025to 30 Dec 2028
- How long will I take part?
- 36 Months
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 8 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Children aged 3-8 years with mandibular primary molars previously treated with either lesion sterilization and tissue repair (LSTR) or conventional pulpectomy at the Department of Pediatric Dentistry, Çanakkale Onsekiz Mart University. Eligible teeth were diagnosed with pulp necrosis or irreversible pulpitis and met the predefined inclusion and exclusion criteria.
Who may be able to join
- The participant is between the ages of 3 and 8 years.
- The participant and their parent(s) have signed informed consent forms agreeing to participate in the study.
- The patient is systemically healthy.
- The patient's cooperation level is sufficient for performing the procedures.
- No history of allergic reactions to the materials and substances to be used.
- Mandibular primary molars diagnosed with pulp necrosis or irreversible pulpitis.
Show all 14Show fewer
- Presence of endodontic-origin gingival abscess or fistula in the involved teeth.
- History of spontaneous pain.
- Presence of radiolucency in the furcation or periapical region, not exceeding one-third of the affected area.
- Presence of deep dentin caries causing pulp exposure.
- Presence of mobility at level 0 or 1 according to Miller's classification (non-pathologic).
- The tooth meets the criteria for restorability.
- Root resorption does not exceed more than four-fifths of the root.
- The tooth meets the criteria for isolation.
Who cannot join
- The participant is not between the ages of 3 and 8 years.
- The participant and/or their parent(s) have not agreed to participate in the study or have not signed the informed consent forms.
- The patient has a systemic disease.
- The patient's cooperation level is insufficient to perform the procedures.
- The patient has a history of allergic reactions to the materials and substances to be used.
- Teeth with external or internal root resorption.
Show all 13Show fewer
- Mechanical or carious perforation of the pulp floor in the affected teeth.
- Radiolucency and bone destruction in the furcation or periapical region exceeding one-third of the affected area.
- Presence of caries that does not cause pulp exposure.
- Pathological mobility according to Miller's classification (>1 score).
- The tooth does not meet the criteria for restorability.
- Root resorption exceeds more than four-fifths of the root.
- The tooth does not meet the criteria for isolation.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Canakkale Onsekiz Mart University
Çanakkale, Kepez, 17100
About this study
Official title: Clinical and Radiographic Evaluation of Lesion Sterilization With Triple Antibiotic Paste Versus Root Canal Treatment With Calcium Hydroxide-iodoform Paste in Mandibular Primary Molars Diagnosed With Necrotic Pulp or Irreversible Pulpitis
The aim of this study was to compare the clinical and radiographic success of conventional root canal treatment and lesion sterilisation tissue repair methods in deciduous molars with necrotic or irreversible pulpitis.
Read the detailed description
This ambidirectional cohort study evaluates the clinical and radiographic outcomes of conventional pulpectomy and lesion sterilization tissue repair (LSTR) in children aged 3-8 years treated at the Department of Pediatric Dentistry, Faculty of Dentistry, Çanakkale Onsekiz Mart University. The study includes mandibular primary molars diagnosed with pulp necrosis or irreversible pulpitis that meet the predefined eligibility criteria.
The null hypothesis is that there is no significant difference in clinical and radiographic success between conventional pulpectomy and LSTR at the evaluated follow-up periods.
The required sample size was calculated based on parameters derived from the study by Moura et al., which compared the clinical and radiographic success of conventional root canal treatment using zinc oxide eugenol with LSTR using a triple antibiotic paste. With a power of 80%, an alpha error probability of 0.05, and an effect size of 0.4020915, the required sample size was calculated using G*Power (version 3.1.9.7; Universität Kiel, Kiel, Germany) as 37 participants per group.
The study cohorts were formed from patients whose mandibular primary molars had previously received either conventional pulpectomy using a calcium hydroxide-iodoform-based root canal filling paste or LSTR using a triple antibiotic paste containing metronidazole, ciprofloxacin, and clindamycin. All treatments were performed by the same operator according to standardized clinical protocols. Eligible previously treated cases were identified separately for each treatment modality, and participants included in the study were randomly selected from the respective eligible treatment pools. Treatment allocation was not performed as part of the research protocol.
The common procedural steps for both treatment modalities included initial clinical and radiographic examination; mandibular alveolar nerve block anesthesia using lidocaine hydrochloride with a vasoconstrictor; rubber dam isolation; removal of carious enamel and cavity preparation using sterile diamond fissure and round burs under water cooling; complete removal of carious dentin and the roof of the pulp chamber; removal of coronal pulp tissue; and irrigation of the pulp chamber with sterile saline.
LSTR cohort:
For LSTR, a triple antibiotic paste containing metronidazole, ciprofloxacin, and clindamycin was used. Minocycline, which has historically been included in triple antibiotic formulations, was excluded because of concerns regarding discoloration associated with tetracycline derivatives and recommendations favoring non-tetracycline antibiotic combinations for non-vital pulp therapy in primary teeth.
The enteric coatings of tablets and capsule shells were removed, and each drug was ground separately into a fine powder using a mortar and pestle. The powders were stored separately in tightly sealed containers protected from light and moisture. Equal quantities of each powder were measured using a precision balance and combined in a 1:1:1 ratio. Equal proportions of propylene glycol and macrogol were used as the liquid vehicle, and the antibiotic powders and vehicle were combined at a 7:1 powder-to-liquid ratio.
The canal orifices were enlarged by approximately 1-2 mm using a small low-speed round bur, and the walls of the pulp chamber were chemically cleaned with phosphoric acid for one minute. After rinsing with sterile saline and drying with cotton pellets, the triple antibiotic paste was applied to the canal orifices and pulp chamber floor. The pulp chamber was sealed with glass ionomer cement, and the tooth was restored with a stainless steel crown.
Pulpectomy cohort:
For conventional pulpectomy, root length was determined using diagnostic radiographs. The root canals were enlarged by 2-3 file sizes beyond the initial file size using K-type endodontic files. During instrumentation, irrigation with 2 mL of 2.5% sodium hypochlorite (NaOCl) was performed after each file. Following canal preparation, the canals were irrigated with 2.5% NaOCl followed by saline and dried using paper points. The canals were then filled with a calcium hydroxide-iodoform paste. The pulp chamber was sealed with glass ionomer cement, and the tooth was restored with a stainless steel crown.
Postoperative periapical radiographs were obtained following treatment. The selected cohorts are being followed longitudinally for clinical and radiographic outcomes. Clinical evaluations are performed at 1, 3, 6, 9, 12, 18, 24, 30, and 36 months, and radiographic evaluations at 3, 6, 12, 18, 24, 30, and 36 months. The 12-month follow-up has been completed, while longer-term follow-up of the established cohorts is continuing.
- Conditions
- Pulpitis - Irreversible, Pulp Necroses, Root Canal Infection
- Being tested
- Lesion sterilization and tissue repair, Conventional pulpectomy
- Keywords
- Lesion Sterilization Tissue Repair, Conventional Pulpectomy
- Medical subject headings
- Dental Pulp Necrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lesion sterilization and tissue repairProcedure or surgery
Lesion sterilization and tissue repair therapy performed with a triple antibiotic mixture.
Conventional pulpectomyProcedure or surgery
Conventional pulpectomy with calcium hydroxide-iodoform based root canal paste.
| Study group | Role | What they receive |
|---|---|---|
| study group | Lesion sterilization and tissue repair Receives: Procedure: Lesion sterilization and tissue repair | |
| control group | Conventional pulpectomy Receives: Procedure: Conventional pulpectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical success
- Absence of spontaneous pain.
- Absence of sensitivity to percussion using dental mirror, pain on biting.
- Absence of swelling.
- Absence of fistula / Exudate.
- Absence of non-physiological mobility
Measured: Follow up will be for three year with recall visits at 1, 3, 6, 12, 18, 24, 30 and 36 months.
Miller Classification - Tooth Mobility
Class 0 Normal (physiologic) movement when force is applied.
Class I Mobility greater than physiologic.
Class II Tooth can be moved up to 1mm or more in a lateral direction (buccolingual or mesiodistal).
Inability to depress the tooth in a vertical direction (apicocoronal).
Class III Tooth can be moved 1mm or more in a lateral direction (buccolingual or mesiodistal).
Ability to depress the tooth in a vertical direction (apicocoronal).
Measured: 1, 3, 6, 12, 18, 24, 30, and 36 months.
Radiographic success
- Absence of furcation or periapical radiolucency.
- Absence of change in the extent of internal or external root resorption other than physiologic resorption.
Measured: Follow up will be for three year with recall visits at 1, 3, 6, 12, 18, 24, 30 and 36 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2025
- Study start1 Oct 2025
- Primary completion4 Oct 2026
- Study completion30 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulpitis - IrreversibleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 59 participants (actual)
- Target duration
- 36 Months
Sponsor and investigators
- Lead sponsor
- Çanakkale Onsekiz Mart University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sümeyye ŞENOL, Çanakkale Onsekiz Mart University
- Investigators
- Sümeyye Şenol, R.A., Principal investigator, Çanakkale Onsekiz Mart UniversityBerkant Sezer, Assoc. Prof., Principal investigator, Çanakkale Onsekiz Mart University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06811636
- Sponsor's protocol ID
- CanakkaleOMU1
- Status last verified
- Oct 2026
- First submitted
- 9 Jan 2025
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: In this study, we are committed to sharing our findings while ensuring the privacy and confidentiality of our participants. Therefore, we will only be disseminating aggregated statistical results derived from the data, rather than individual participant data.